"Ovarian Channel" Cancer

Description
Although this cancer include malignant tumors in the category, until now the cause of the Fallopian tubes cancer is unknown. These cancers most commonly strike women who have menopause, although in some cases are also young women who experience it also.

Symptoms
In stage I, cancer is confined to the oviduct only. However, if you've reached the stage II, can strike up to the pelvis. Even if it had reached stage II and IV, the cancer reaches the Fallopian tubes into the pelvis and spreads out to other parts of the body.

Medical
The only medical treatment for this disease is by appointment cancer. After a new elected to do radiation to kill the roots of cancer.

WORLD CANCER DAY

WORLD CANCER DAY

World Cancer Day is marked on 4 February to raise awareness of cancer and to encourage its prevention, detection, and treatment. It is led by the International Union Against Cancer (UICC), a global consortium of more than 280 cancer-fighting organizations in over 90 countries. World Cancer Day targets the public through global communications marking, and encourages policy makers and UICC member organizations to make cancer a political priority.

The campaign emphasizes that 43% of cancers can be prevented through these healthy behaviors:

* Provide a smoke-free environment for children
* Be physically active, eat a balanced, healthy diet, and avoid obesity
* Learn about vaccines for virus-related liver and cervical cancers
* Avoid over-exposure to the sun

Blood test detects ovarian cancer early

Researchers have developed what they believe is the first blood test that accurately detects ovarian cancer at an early stage.“The ability to recognize almost 100% of new tumours will have a major impact on the high death rates of this cancer,” senior author Dr. Gil Mor, from Yale University School of Medicine in New Haven, Connecticut, said in a statement. “We hope this test will become the standard of care for women having routine examinations.”

In 2005, Mor’s team first described a panel of biomarkers that can detect stage I and II ovarian cancer.

In the present trial, reported in the medical journal Clinical Cancer Research, the researchers expanded the panel from four proteins to six, and used a sophisticated assay system to measure protein levels in 362 healthy women and 156 patients newly diagnosed with ovarian cancer.

Alone, none of the biomarkers could distinguish the cancer patients from the healthy comparison group, the researchers report. When all six biomarkers were measured, however, the test identified 95 percent of the cancer patients.

A larger evaluation of the biomarker assay is currently underway.

Beware Of Breast Cancer

Breast cancer is a cancer of the glandular breast tissue.
Worldwide, breast cancer is the fifth most common cause of cancer death (after lung cancer, stomach cancer, liver cancer, and colon cancer). In 2005, breast cancer caused 502,000 deaths (7% of cancer deaths; almost 1% of all deaths) worldwide. Among women worldwide, breast cancer is the most common cause of cancer death.

In the United States, breast cancer is the third most common cause of cancer death (after lung cancer and colon cancer). In 2007, breast cancer is expected to cause 40,910 deaths (7% of cancer deaths; almost 2% of all deaths) in the U.S. Among women in the U.S., breast cancer is the most common cancer and the second-most common cause of cancer death (after lung cancer). Women in the U.S. have a 1 in 8 lifetime chance of developing invasive breast cancer and a 1 in 33 chance of breast cancer causing their death. In the U.S., both incidence and death rates for breast cancer have been declining in the last few years. Nevertheless, a U.S. study conducted in 2005 by the Society for Women's Health Research indicated that breast cancer remains the most feared disease, even though heart disease is a much more common cause of death among women.
The number of cases worldwide has significantly increased since the 1970s, a phenomenon partly blamed on modern lifestyles in the Western world. Because the breast is composed of identical tissues in males and females, breast cancer also occurs in males, though it is less common.

Prevention

A. Phytoestrogens and soy
Phytoestrogens such as found in soybeans have been extensively studied in animal and human in-vitro and epidemiological studies. The literature support the following conclusions:

1. Plant estrogen intake, such as from soy products, in early adolescence may protect against breast cancer later in life.
2. Plant estrogen intake later in life is not likely to influence breast cancer incidence either positively or negatively.

B. Folic Acid C. Avoiding exposure to secondhand tobacco smoke

Treatment

The mainstay of breast cancer treatment is surgery when the tumor is localized, with possible adjuvant hormonal therapy (with tamoxifen or an aromatase inhibitor), chemotherapy, and/or radiotherapy. At present, the treatment recommendations after surgery (adjuvant therapy) follow a pattern. This pattern is subject to change, as every two years, a worldwide conference takes place in St. Gallen, Switzerland, to discuss the actual results of worldwide multi-center studies. Depending on clinical criteria (age, type of cancer, size, metastasis) patients are roughly divided to high risk and low risk cases, with each risk category following different rules for therapy. Treatment possibilities include radiation therapy, chemotherapy, hormone therapy, and immune therapy.
In planning treatment, doctors can also use PCR tests like Oncotype DX or microarray tests like MammaPrint that predict breast cancer recurrence risk based on gene expression. In February 2007, the MammaPrint test became the first breast cancer predictor to win formal approval from the Food and Drug Administration. This is a new gene test to help predict whether women with early-stage breast cancer will relapse in 5 or 10 years, this could help influence how aggressively the initial tumor is treated.